Moderna launches second phase trial for its coronavirus vaccine

On Friday, Moderna dosed the first participants in a trial to test whether its coronavirus shot can block infection, but experts have questioned the medical validity of its first trial as well as its financial gains.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news